Navigation Links
Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry
Date:10/7/2009

NEW HAVEN, Conn., Oct. 7 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of multi-antibiotic resistant infections, today announced that Rib-X Co-Founder and Chair of the Scientific Advisory Board, Sterling Professor of Molecular Biophysics and Biochemistry at Yale University and a Howard Hughes Medical Institute Investigator, Thomas A. Steitz, Ph.D., has been awarded the Nobel Prize in Chemistry for 2009 by The Royal Swedish Academy of Sciences.

Dr. Steitz shares the prize with Venkatraman Ramakrishnan of the MRC Laboratory of Molecular Biology, Cambridge, United Kingdom, and Ada E. Yonath, Weizmann Institute of Science, Rehovot, Israel. All three were praised for their work on using "X-ray crystallography to map the position for each and every one of the hundreds of thousands of atoms that make up the ribosome." Dr. Ramakrishnan is also on Rib-X's Scientific Advisory Board.

"Rib-X would like to extend its congratulations to Drs. Steitz, Ramakrishnan and Yonath on receiving the most esteemed award for scientific endeavors and accomplishments," said Dr. Susan Froshauer, President and Chief Executive Officer, Rib-X. "As one of our co-founders, Dr. Steitz recognized the importance of the ribosome early on, and he continues to perform a valuable role to us as the Chair of the Scientific Advisory Board."

"I am excited by the prospect that our work on the structure of the ribosome and mechanisms of antibiotic binding is leading to potential new chemical classes which have the potential to treat a wide variety of multi-drug resistant bacterial infections," commented Dr. Steitz.

Dr. Peter Moore, Sterling Professor of Chemistry at Yale University and Dr. Harry Noller, Robert Louis Sinsheimer Professor of Molecular Biology at the University of California, Santa Cruz, also co-founders and part of Rib-X's Scientific Advisory
'/>"/>

SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
2. Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council
3. Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
4. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
5. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
6. Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin
7. Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
8. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
9. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... SAN DIEGO, Nov. 25 NuVa...any focused on developing products for minimally d...nced today that it will host a conference call on ...p.m. PT. The conference call will focus on curren...,s products and will include comments from managem...
(Date:11/25/2009)...EW YORK, Nov. 25 Reportlinker.com ...ilable in its catalogue: ,, Intranasal Drug De...www.reportlinker.com/p0164267/Intranasal-Drug-Deli...US intranasal drug delivery market is witnessing a...elivery of conventional local therapeutic drugs to...
(Date:11/25/2009)... VIEW, Calif., Nov. 25 ChemoCent...cal data from the Company,s PROTECT-1 (the Prospec... disease Trial) of Traficet-EN(TM) (CCX282-B) in p...monstrated clinical efficacy with a favorable safe...ed evidence of clinical efficacy in the reduction ...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Dense Breasts Raise Risk of Cancer Recurrence 60997 1Dense Breasts Raise Risk of Cancer Recurrence 60997 2Dense Breasts Raise Risk of Cancer Recurrence 60997 3Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 60994 1Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 60994 2Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 60994 3American Academy of Physician Assistants Applauds U S House of Representatives for Passing Health Care Reform Bill 60989 1American Academy of Physician Assistants Applauds U S House of Representatives for Passing Health Care Reform Bill 60989 2
... 09, 2007 /PRNewswire-FirstCall/ --,Telik, Inc. an...enter Phase 2 trial of the triplet combination of ... and paclitaxel will be,presented at the 98th annu...Research (AACR) in Los Angeles. Preclinical studie...tic cancer cell growth,inhibition with TELCYTA in ...
...SS WIRE)--Apr 11, 2007 - New data,supporting the c...,the most advanced investigational oral protease i...HCV) infection, will be presented,at the 42nd Annu...dy of the Liver (EASL) in Barcelona this week. In ...een accepted for presentation,at the EASL conferen...
Other Medicine Technology:Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 2Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 3Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 2Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 3Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 4Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 5Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 6
(Date:11/26/2009)...t 25 years, the number of Americans living with di...llion in 2009 to 44.1 million in 2034. Over the sa..., rising from $113 billion to $336 billion, even w...archers based at the University of Chicago report ...number of those with diabetes covered by Medicare ...
(Date:11/26/2009)...igger thrill when on an emotional rollercoaster, s...Day News) -- Call it the fear factor meets the jub...pectators -- especially those who root for the win...,s a closely contested match and victory was in do... , Chew on that this Thanksgiving weekend as yo...
(Date:11/26/2009)... Research Triangle Dental (RTDental),...Carolina, today announced the expansion of its ser... Dentist, Dr. Doug Macmillan. , ...Dental is pleased to announce that Dr. Doug Macmil...completed an additional advanced training seminar....
(Date:11/25/2009)...EDINA, Minn., Nov. 25 W...f their dentist. But a chiropractor can also give...emporal-Mandibular Joint, which is where your jaw ...oral bone). ,, The most common symptoms associ...licking or popping of the jaw. But many other sym...
(Date:11/25/2009)... TORONTO and CALGARY, Nov. 25 /PRNewswire/ - Senti...etic Resonance Imaging (MRI) coils and software an...oftware enabling technologies, have introduced a w...zation software. ,, This innovative interface i...medical imaging offering in the market. Calgary Sc...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
... of Delphon Industries and industry leader in Elec...today the appointment of Diablo Sales & Market...pport in the western United States and Western Can...terials used in injection molding and extrusion fo...
...ion for Homecare supports expanded anti-fraud effo...ice (DOJ) and the Department of Health and Human S...Medicare. The two agencies outlined plans for expa...e stepped-up DOJ-HHS effort, the American Associat...
...dition , , WEDNESDAY, May 20 (HealthDay Ne...sk of autism, particularly in boys, has been ident...f 1,046 members of families with at least two sons...ported. , This variant of the gene, which helps mo...
...y says , , WEDNESDAY, May 20 (HealthDay Ne...hospital with the intense chest pain that doctors ...r artery-opening procedures within a few hours, a ...is often an issue about whether such assessment an...
... when even teens who have never tried a drop of al... and graduation are big events and there will be m...rtunities for alcohol to be served. , Assume tha...or the Advancement of Science (AAAS). So start tal...
...hildren,s Pediatric Disorders , , SANTA MONICA, C... world leader in orthopaedic patient care, researc...day the Renee and Meyer Luskin Children,s Clinic o...world-class pediatric orthopaedic care. Renee and ...
Other Medicine News:Health News:TouchMark Announces New Sales Representative 2Health News:American Association for Homecare Supports Expanded Federal Efforts by DOJ and HHS to Combat Medicare Fraud 2Health News:American Association for Homecare Supports Expanded Federal Efforts by DOJ and HHS to Combat Medicare Fraud 3Health News:American Association for Homecare Supports Expanded Federal Efforts by DOJ and HHS to Combat Medicare Fraud 4Health News:Gene Gives Clues to Why Autism More Common in Boys 2Health News:When Chest Pain Requires Quick Action in ER 2Health News:When Chest Pain Requires Quick Action in ER 3Health News:Use science to convince teens a sober prom is better, AAAS says 2Health News:World-Class Pediatric Orthopaedic Clinic Now Open for Kids 2
ACE SCFE Screw
4.0 mm and 6.5 mm Cannulated Screws
...bles fixation of humeral shaft fractures while avo...associated with antegrade nailing. , ,In addition,...ng using a nail-mounted targeting device. This dev...th the patient in the prone position. In cases tha...
...edical technology company and a key participant in...es a new generation Automated Coagulation Timer. T...electromechanical coagulation instrument designed ... citrated whole blood, and plasma samples. Clottin...
Medicine Products: